#EXCLUDE#
#EXCLUDE#
#EXCLUDE#
#EXCLUDE#

Find prevention records by subject or service provider/commissioner name

  • Key to icons

    • Journal Prevention service example
    • Book Book
    • Digital media Digital media
    • Journal Journal article
    • Free resource Free resource

Results for 'social prescribing'

Results 1 - 10 of 37

ConnectWELL

ConnectWELL

Introducing ConnectWELL - a social prescribing service – initially funded and piloted in 2014 by NHS Rugby CCG, which aims to improve health and wellbeing for patients and clients. ConnectWELL provides Health Professionals with just one, straightforward referral route to the many Voluntary and Community Sector organisations, groups and activities that can address underlying societal causes, manage or prevent compounding factors of ill-health. ConnectWELL has over 900 organisations and activities, ranging from Carers’ support, community groups, disability services, Faith / Religious / Cultural Activities, Housing / Homelessness Support, Mentoring, Music Groups, and volunteering opportunities.

Improving outcomes for carers via GP surgeries: implications for commissioners

OXFORD BROOKES UNIVERSITY. Institute of Public Care, CARERS BUCKS
2017

Reports on a pilot project, funded by the Chiltern Clinical Commissioning Group, which sought to help GPs identify previously unknown carers and improve carer experience and wellbeing outcomes. The pilot offered carers a free health and wellbeing check with a carer support worker and a social prescription to access services provided by Carers Bucks where appropriate. The health and wellbeing check used the 'Carers Star' covering seven outcome areas: health, the caring role, managing at home, time for yourself, how you feel, finances, and work. A total of 203 carers attended the carers clinics. Approximately a quarter of carers were caring for someone with dementia and a quarter were caring for someone with a physical disability. Analysis of comments received by carers attending the clinic identified three key themes: carers appreciated the clinics because they felt it was rare for anyone to ‘care’ for them; carers felt listened to; and received useful information about support they didn’t know existed. The paper maps learning from the project against the Institute of Public Care commissioning cycle and makes recommendations for commissioners.

Evaluation of the Rotherham mental health social prescribing service 2015/16/-2016/17

DAYSON Chris, BENNETT Ellen
2017

Updated findings of an independent evaluation of the Rotherham Social Prescribing Mental Health Service, a service to help users of secondary mental health services build their own packages of support by accessing voluntary activity in the community. Voluntary activities covered four broad themes: befriending and peer support, education and training, community activity groups and therapeutic services. The service was delivered in partnership by Rotherham, Doncaster and South Humber NHS Foundation Trust (RDASH) and a group of local voluntary sector organisations led by Voluntary Action Rotherham. The evaluation looks at the impact of the service on the well-being of service users, the wider outcomes and social benefits, the impact of the service on discharge from secondary mental health services and explores the potential economic benefits of the service. It reports that over the two years of the evaluation, the service had engaged with more than 240 users of secondary mental health services in Rotherham. The service made a significant and positive impact on the well-being of mental health service users, with more than 90 per cent of service users making progress against at least one wellbeing outcome measure. Service users also experienced a range of wider benefits, including taking part in training, volunteering, taking up physical activity and sustained involvement in voluntary sector activity. Initial evidence about discharge from mental health services was also positive. The evaluation estimates that the well-being benefits experienced by service users equate to social value of up to £724,000: a social return on investment of £1.84 for every £1 invested in the service.

Social prescribing: less rhetoric and more reality. A systematic review of the evidence

BICKERDIKE Liz, et al
2017

Objectives: Social prescribing is a way of linking patients in primary care with sources of support within the community to help improve their health and well-being. Social prescribing programmes are being widely promoted and adopted in the UK National Health Service and this systematic review aims to assess the evidence for their effectiveness. Setting/data sources: Nine databases were searched from 2000 to January 2016 for studies conducted in the UK. Relevant reports and guidelines, websites and reference lists of retrieved articles were scanned to identify additional studies. All the searches were restricted to English language only. Participants: Systematic reviews and any published evaluation of programmes where patient referral was made from a primary care setting to a link worker or facilitator of social prescribing were eligible for inclusion. Risk of bias for included studies was undertaken independently by two reviewers and a narrative synthesis was performed. Primary and secondary outcome measures: Primary outcomes of interest were any measures of health and well-being and/or usage of health services. Results: A total of 15 evaluations of social prescribing programmes were included. Most were small scale and limited by poor design and reporting. All were rated as a having a high risk of bias. Common design issues included a lack of comparative controls, short follow-up durations, a lack of standardised and validated measuring tools, missing data and a failure to consider potential confounding factors. Despite clear methodological shortcomings, most evaluations presented positive conclusions. Conclusions: Social prescribing is being widely advocated and implemented but current evidence fails to provide sufficient detail to judge either success or value for money. If social prescribing is to realise its potential, future evaluations must be comparative by design and consider when, by whom, for whom, how well and at what cost.

Evaluation of Doncaster Social Prescribing Service: understanding outcomes and impact

DAYSON Chris, BENNETT Ellen
2016

An evaluation of the Doncaster Social Prescribing Service, providing an analysis of outcomes for service users and the costs and benefits of the service between August 2015 and July 2016. It uses interviews with staff and key stakeholders from across health and social care, and users of the service; self-evaluation questionnaires from 292 people using the Service; and quality of life surveys completed by 215 users of the Service. The Social Prescribing Service reached more than 1,000 people referred by their GP, Community Nurse or Pharmacist and enabled almost 600 local people to access support within the community during the evaluation period. The main reasons for referral were a long term health or mental health condition. Positive outcomes for clients included improvements in health related quality of life (HRQL), social connectedness, and financial well-being. However, there was little evidence to suggest a reduction in the use of secondary care and inpatient stays. In health terms, the evaluation estimates that for every £1 of the £180,000 funding spent, the Service produced more than £10 of benefits in terms of better health.

The Rotherham Social Prescribing Service for people with long-term conditions: a GP perspective

DAYSON Chris, MOSS Bronwen
2017

This thematic summary report explores the benefits and challenges of the Rotherham Social Prescribing from the perspective of GPs. It draws on qualitative interviews with 10 GPs and two Practice Managers and data extract from one GP surgery. It paints an overwhelmingly positive picture of the impact of Social Prescribing on GPs and patients, and highlights how the Service has quickly become a central component in a GPs options when treating the causes and consequences of long-term health conditions. Themes that emerged from GP interviews included: enabling GPs to take a holistic approach to health, developing GPs awareness of community-level support, reductions in GP workloads and reduction in medial prescribing. When GPs were asked how Social Prescribing benefitted patients, they referred to reductions in social isolation and loneliness; prevents family and carer breakdown; and providing person centred services. They also provided reflections on Rotherham Social Prescribing model, and what worked effectively.

The Rotherham Social Prescribing Service for People with long-term conditions: evaluation update

DAYSON Chris, DAMM Chris
2017

An updated assessment of the social and economic impact of the Rotherham Social Prescribing Service between September 2012 and March 2016. Originally commissioned as a two-year pilot in 2012 the service is now funded until 2018 through the Better Care Fund. Its two core features are: advisors providing a single gateway to voluntary and community sector (VCS) support for GPs and service users (advisors assess the support needs of patients and carers before referring on to appropriate VCS services) and a grant funding programme for VCS activities to meet the needs of service users. The evaluation reports that between September 2012 and March 2016 the Rotherham Social Prescribing Service supported more than 3,000 local people with long-term health conditions and their carers. It identifies reductions in service users’ use of secondary care, reduced admissions to Accident and Emergency, and improvements in the well-being of service users. Wider benefits seen in the VCS across Rotherham, include additional investment; developing and promoting social action and volunteering; and the development of a ‘micro-commissioning’ model. The evaluation also consistently demonstrated costs avoided by the NHS, with figures across the first four years of service equating to an estimated £647,000 of NHS costs avoided: an initial return on investment of 35 pence for each pound (£1) invested.

Making sense of social prescribing

POLLEY Marie, et al
2017

This guide provides an overview of the key aspects of social prescribing. Commissioned by NHS England, the guide has been co-produced by people with practical experience of designing, commissioning and delivering social prescribing schemes. Sections of the guide cover: the definition and key components of social prescribing, the reasons for developing social prescribing schemes; examples of different models; what makes a good link worker; what makes a good referral; governance and risk management; and evaluating schemes. The guide also includes links to additional resources.

Report of the annual social prescribing network conference

SOCIAL PRESCRIBING NETWORK
2016

Report of the annual social prescribing network conference, which sets out a definition of social prescribing, outlines principles for effective service provision and the steps needed to evaluate and measure the impact of social prescribing. It also includes an analysis of a pre-conference survey, completed by 78 participants to explore their experience of social prescribing. Key ingredients identified that underpin social prescribing included: funding, healthcare professional buy-in, simple referral process, link workers with appropriate training, patient centred care, provision of services, patient buy-in and benefits of social prescribing. The benefits of social prescribing fell into six broad headings: physical and emotional health and wellbeing; behaviour change; cost effectiveness and sustainability; capacity to build up the voluntary community; local resilience and cohesion; and tackling the social determinants of ill health. Afternoon sessions covered the following topics: obtaining economic data on social prescribing; engaging different stakeholders in social prescribing; standards and regulations that could be applied to social prescribing services; qualities and skills necessary to commission high quality social prescribing services; designing research studies on social prescribing. Short case studies are included. There was consensus from participants that social prescribing provides potential to reduce pressures on health and care services through referral to non-medical, and often community-based, sources of support.

A review of the evidence assessing impact of social prescribing on healthcare demand and cost implications

POLLEY M., et al
2017

This paper critically appraises the current evidence as to whether social prescribing reduces the demand for health services and is cost effective. It draws on the results of a systematic review of online databases which identified 94 reports, 14 of which met the selection criteria. They included studies on the effect of social prescribing on demand for general practice, the effect on attendance at accident and emergency (A&E) and value for money and social return on investment assessments. The evidence broadly supports the potential for social prescribing to reduce demand on primary and secondary care, however, the quality of the evidence is weak. It also identifies encouraging evidence that social prescribing delivers cost savings to the health service, but this is not proven or fully quantified. In conclusion, the paper looks at the possible reasons for the growth in scale and scope of social prescribing across the UK and makes recommendations for more evaluations of on-going projects to assess the effectiveness of social prescribing.

Results 1 - 10 of 37

#EXCLUDE#
Ask about support on integration, STPs and transformation
ENQUIRE
Related SCIE content
Related NICE content
Related external content
Visit Social Care Online, the UK’s largest database of information and research on all aspects of social care and social work.
SEARCH NOW
Submit prevention service example
SUBMIT
What do you think about SCIE's work?
FEEDBACK
#EXCLUDE#
#EXCLUDE#
#EXCLUDE#